🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of the study is to investigate the safety, tolerability and effica...
Status
Recruiting
Location
Save Sight Institute
Start Date
2025-08-29
Trial ID
NCT06628947
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of OMS302...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01454063
The goal of this study is to determine the safety (but not efficacy in prev...
Status
Suspended
Location
Rush Eye
Start Date
2023-01
Trial ID
NCT02590523
Treatments Being Tested
The Center for Disease Control (CDC) and World Health Organization (WHO) ha...
Status
Completed
Location
University of Louisville
Start Date
2020-10-27
Trial ID
NCT04811339
The purpose of this study is to determine if the use of prophylactic bismut...
Status
Terminated
Location
Marina Rogova
Start Date
2018-05-20
Trial ID
NCT03535272
Treatments Being Tested
In this study, investigators will compare the efficacy and safety of intrav...
Status
Completed
Location
Pediatric Emergency Center, Al Saad
Start Date
2012-10
Trial ID
NCT02145520
Treatments Being Tested
The purpose of this study is to evaluate the effect of OMS302 on the signs ...
Status
Terminated
Location
Omeros Investigational Site
Start Date
2014-02
Trial ID
NCT02093689
Treatments Being Tested
The purpose of this study is to determine the safety, efficacy and pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01579565
This study investigates the effect of tranexamic acid, a medication that he...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-01
Trial ID
NCT05672407
Treatments Being Tested
Purpose: It is unknown whether instillation of a drop of anesthetic ophthal...
Status
Terminated
Location
Dianne Schlachter
Start Date
2020-06-30
Trial ID
NCT04229771
Treatments Being Tested